Benchmark Litigation California: Litigation Stars

Stephen Taylor and Jonathan Patchen have been named as Benchmark Litigation Stars – 2019 and as State Litigation Stars by Benchmark Litigation California:

In addition, Benchmark Litigation recognized the firm with a Tier 2 ranking in San Francisco and the firm’s Intellectual Property practice received a Tier 2 ranking in California.

Benchmark Litigation California’s editorial notes that “San Francisco boutique Taylor & Patchen makes a showing as one of the city’s growing cult of shops that are giving bigger shops a run for their money.”

Additionally, the publication provides descriptions of Mr. Patchen’s work highlights, including that he “was lead counsel representing a San Francisco couple as plaintiffs, including at pretrial and trial proceedings in San Francisco Superior Court, seeking relief on claims including breach of fiduciary duty and breach of contract. He obtained a substantial stipulated judgment mid-trial. Patchen is also lead counsel for the two founders of Flexus Biosciences in defense of a trade secret misappropriation action filed in Delaware Superior Court in which the Plaintiff has claimed up to $2.5 billion in damages.…He is also acting as lead counsel in defending one of two founders of Otto Motto in a confidential two-week arbitration related to Uber’s acquisition of Otto Motto. The claimed damages exceed $150 million. Patchen also represented the founder of Palo Alto Networks in defense of a trade secret misappropriation and patent infringement case claiming damages in excess of $80 million. He successfully moved and argued for summary judgment on the plaintiff’s trade secret misappropriation claim, resulting in a settlement that has recently been upheld on appeal.

Mr. Taylor is described as having “represented Tyler Shultz in connection with threatened trade secret misappropriation claims designed to discredit him as a witness and ‘whistleblower’ breaking the story about Theranos, the Silicon Valley startup that generated much celebrity and investor capital on its claims to have revolutionized the practice of blood testing, only to have those claims proven fraudulent, leading to a high-profile implosion and, ultimately, bankruptcy.”

The results of Benchmark Litigation are decided following a four- to six-month research period (depending on region) where researchers conduct extensive interviews with litigators and their clients to identify the leading litigators and the firms. During this process, researchers examine recent casework and ask individual litigators to offer their professional opinions on piers. More about the methodology can be found here.

Categories: Firm News